CYDECTIN TRICLAMOX 5 MG/ML + 200 MG/ML POUR-ON SOLUTION FOR CATTLE

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

MOXIDECTIN, TRICLABENDAZOLE

Διαθέσιμο από:

Zoetis Ireland Limited

Φαρμακολογική κατηγορία (ATC):

QP54AB52

INN (Διεθνής Όνομα):

MOXIDECTIN, TRICLABENDAZOLE

Δοσολογία:

5/200

Φαρμακοτεχνική μορφή:

Pour-on Solution

Τρόπος διάθεσης:

LM-Licensed Merchant

Θεραπευτική ομάδα:

Bovine

Θεραπευτική περιοχή:

Moxidectin, combinations

Θεραπευτικές ενδείξεις:

Endectoparasiticides

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2013-12-09

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Pour-on solution.
A clear, amber liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
Each ml contains:
Active substances
Moxidectin
5.0
mg
Triclabendazole
200.0 mg
Excipients
Butylhydroxytoluene (E321) 5.0
mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_1_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_1_
_8_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cattle:
Treatment of mixed trematode (fluke) and nematode infections and
certain arthropod infestations caused by
moxidectin and triclabendazole sensitive strains of:
The product has a persistent effect in preventing re-infection by_
Ostertagia ostertagi_ and by_ Dictyocaulus viviparus_ for
5 weeks after a single dose.
4.3 CONTRAINDICATIONS
Do not use in cases of known hypersensitivity to the active
substance(s) or to any of the excipient(s).
Parasite
Adult stage
Inhibited stages
NEMATODES
L4
GASTRO-INTESTINAL NEMATODES:
_Haemonchus placei_
_Ostertagia ostertagi_
_Trichostrongylus axei_
_Nematodirus helvetianus_
_Cooperia oncophora_
_Cooperia punctata_
_Oesophagostomum radiatum_
_Bunostomum phlebotomum_
RESPIRATORY TRACT NEMATODE:
_Dictyocaulus viviparus_
TREMATODES
LIVER FLUK